Welcome to our dedicated page for Advansix SEC filings (Ticker: ASIX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The AdvanSix Inc. (NYSE: ASIX) SEC filings page on Stock Titan brings together the company’s regulatory disclosures from the U.S. Securities and Exchange Commission, with AI-powered tools to help interpret complex documents. AdvanSix is a diversified chemistry company focused on nylon solutions, plant nutrients and chemical intermediates, and its filings provide detailed insight into how these businesses perform and are governed.
Key filings for ASIX include Form 10-K annual reports, where AdvanSix presents a comprehensive view of its operations, risk factors and financial results across product lines such as Nylon, Caprolactam, Plant Nutrients and Chemical Intermediates. Form 10-Q quarterly reports update investors on recent performance, including sales by product line, raw material pass-through pricing and the effects of plant turnarounds, capital projects and programs like SUSTAIN and 45Q carbon capture tax credits.
AdvanSix also files numerous Form 8-K current reports to disclose material events. Recent examples include announcements of quarterly and annual financial results, dividend declarations, amendments to its credit agreement, changes in executive leadership, board appointments and stockholder voting outcomes on items such as the amended and restated stock incentive plan and amendments to the certificate of incorporation.
On this page, Stock Titan’s AI summarizes lengthy ASIX filings, highlights important sections, and makes it easier to locate information on topics such as governance changes, compensation plans, capital structure and direct financial obligations. Users can also track relevant filings that may include insider-related information, such as equity incentive plans, alongside the core 10-K, 10-Q and 8-K documents.
AdvanSix Inc. (ASIX) Form 3 filing: Daryl Roberts, identified as a Director, filed an initial Section 16 statement reporting zero shares of AdvanSix common stock beneficially owned. The event date triggering the filing is 09/02/2025 and the filing was signed on 09/08/2025 by Achilles B. Kintiroglou on behalf of the reporting person. No derivative holdings or indirect ownership are disclosed.
AdvanSix Inc. (ASIX) Form 3 reports that Dana C. O'Brien, listed at the provided address, is a director of the issuer and filed an initial Section 16 statement. The filing shows zero shares of common stock beneficially owned, and the form is signed on behalf of the reporting person. This is a routine initial ownership disclosure with no recorded beneficial ownership reported.
AdvanSix Inc. (ASIX) insider sale reported on Form 4. Achilles B. Kintiroglou, SVP and General Counsel, sold 571 shares of AdvanSix common stock on 09/02/2025 at $21.20 per share. After the sale, the reporting person beneficially owned 30,842 shares. The filing notes the sale was executed under a Rule 10b5-1 trading plan adopted by the reporting person on 11/12/2024, and the Form 4 was signed on 09/03/2025. The disclosure shows a routine, pre-arranged disposition by an officer with a clear compliance disclosure.
Notice of proposed sale under Rule 144: This Form 144 indicates that Achilles Kintiroglou intends to sell 571 shares of AdvanSix Inc. common stock through Merrill Lynch (NYC) with an aggregate market value of $12,105.20, with an approximate sale date of 09/02/2025. The shares were acquired on 02/28/2025 through the vesting of a restricted stock unit award granted under the issuer's equity compensation plan. The filing also reports three prior sales in the past three months of 571 shares each on 06/02/2025, 07/02/2025, and 08/01/2025, with gross proceeds of $13,504.15, $14,189.35, and $11,522.78 respectively. The filer attests not to possess undisclosed material adverse information.
AdvanSix Inc. appointed Dana O’Brien and Daryl Roberts to its Board of Directors effective September 2, 2025, increasing the Board to nine members with eight qualifying as independent under NYSE standards. Ms. O’Brien will serve on the Nominating and Governance Committee and the Compensation and Leadership Development Committee, and Mr. Roberts will serve on the Health, Safety and Environmental Committee and the Compensation and Leadership Development Committee.
Ms. O’Brien most recently served as Senior Vice President and Chief Legal Officer of Olin Corporation and held senior legal roles at several public companies. Mr. Roberts is Senior Vice President and Chief Operations and Engineering Officer of DuPont de Nemours Inc. There are no related-person transactions or family relationships disclosed, and both will receive standard non-employee director compensation described in the company proxy.